The findings manifested that CA3 can represent a new inhibitor of YAP1 to significantly inhibit YAP1/TEAD transcriptional activity, targeting radiation-resistant esophageal adenocarcinoma cells with CSC characteristics [135]. Here, YAP1 is linked to esophageal adenocarcinoma.